
|Videos|July 8, 2022
Use of aflibercept in the management of diabetic retinopathy
Author(s)David Hutton, Emily Kaiser Maharjan
Lloyd Clark, MD, highlights his ASRS presentation focusing on the PANORAMA study detailing the use of aflibercept in the management of diabetic retinopathy.
Advertisement
Lloyd Clark, MD, of Palmetto Retina Center, previews his ASRS poster, which focuses on the PANORAMA Study, which reviews the use of aflibercept in the management of diabetic retinopathy. He will present his poster during a reception on July 15 at this year’s American Society of Retina Specialists meeting in New York.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Increasing the knowledge base of GA is key to individualizing patient therapy
2
EYDENZELT, Celltrion’s biosimilar referencing EYLEA, approved by FDA
3
REGENXBIO completes enrollment in ATMOSPHERE and ASCENT trials of sura-vec in wet AMD
4
Quantifying intermittent retinal capillary perfusion in RVO and PDR
5